April 2, 2026 — Lantern Pharma (NASDAQ: LTRN) announced it will host an investor, analyst and shareholder briefing on April 9, 2026, at 8:30 a. m.
April 2, 2026 — Lantern Pharma (NASDAQ: LTRN) announced it will host an investor, analyst and shareholder briefing on April 9, 2026, at 8:30 a. m.
April 2, 2026 — Disseminated on behalf of Nevada Organic Phosphate Inc. (CSE: NOP) (OTCQB: NOPFF) and may include paid advertising.
April 2, 2026 — Datavault AI (NASDAQ: DVLT), an AI-driven data monetization, RWA tokenization and Web 3. 0 infrastructure company, and Demora Foundation announced a Technology Integration Agreement naming Datavault AI as the formal AI data intelligence and RWA tokenization technology partner for the K-Entertainment & K-Wave Global Platform, spanning Atlanta, Dallas and the New York Tri-State area.
April 1, 2026 — Mississippi Governor Tate Reeves has vetoed two measures aimed at broadening access to medical cannabis, even as he approved a separate measure to advance research into a psychedelic drug with potential therapeutic uses. The cannabis industry will be disappointed that the reforms intended in the vetoed bills didn’t become law, but as established firms like Green Thumb Industries Inc.
April 1, 2026 — Disseminated on behalf of CMX Gold & Silver Corp. (CSE: CXC) (OTC: CXXMF) and may include paid advertising.
April 1, 2026 — Nightfood Holdings (OTCQB: NGTF) (d. b.
April 1, 2026 — Publishing research in peer-reviewed journals plays a central role in ensuring the credibility and reliability of scientific findings. Companies that consistently publish their findings often strengthen their credibility with both regulators and the medical community.
April 1, 2026 — Disseminated on behalf of Ucore Rare Metals Inc. (TSX.
April 1, 2026 — Massimo Group (NASDAQ: MAMO) reported financial results for the fiscal year ended Dec. 31, 2025, highlighting a significant expansion in gross margin to approximately 37.
April 1, 2026 — A2Z Cust2Mate Solutions Corp. (NASDAQ: AZ) reported audited financial results for the year ended Dec.
April 1, 2026 — As the week gets to the mid-point, spot gold has been trading in a tight range around $4,500 an ounce as a firmer dollar, elevated yields on Treasuries and a hawkish Fed exert a drag on prices of the precious metal. While precious metal markets are currently experiencing a correction, the long-term prospects of these metals remain strongly bullish due to underlying structural drivers like de-dollarization and continuing accumulation by central banks.
April 1, 2026 — Stocks of memory chip manufacturers fell sharply this week as new signals suggested that the global shortage of memory chips may begin to ease. The decline wiped out nearly $100 billion in market value across major U.
April 1, 2026 — Scientists have overcome production barriers that have plagued doxorubicin manufacturing since the 1970s by engineering bacteria that generate 180% more of the critical chemotherapy drug than current methods achieve. The breakthrough addresses molecular bottlenecks that forced pharmaceutical companies to rely on expensive, multi-step processes despite treating over one million cancer patients annually with the medication.
April 1, 2026 — This article has been disseminated on behalf of Wheaton Precious Metals Corp. and may include paid advertising.
April 1, 2026 — Linkers Industries Limited (NASDAQ: LNKS) announced its board has approved a 1-for-250 reverse share split of its Class A and Class B ordinary shares, with post-split trading set to begin April 6, 2026, under the same ticker and a new CUSIP. The move, intended to support continued Nasdaq listing compliance, will proportionally adjust outstanding shares, par value and warrants, while maintaining shareholder ownership percentages aside from fractional share rounding.
April 1, 2026 — The company’s AI-driven digital asset trading platform combines artificial intelligence, blockchain settlement, and EU-compliant market infrastructure, and CEO Patrick Gruhn is expected to outline the company’s strategy and engage with investors at the Emerging Growth Conference, taking place online April 1, 2026. Perpetuals operates technology supporting a CySEC-authorized multilateral trading facility under European regulatory frameworks.
April 1, 2026 — NanoViricides, Inc. (NYSE American: NNVC) announced that a Phase II clinical trial of its antiviral candidate NV-387 for the treatment of MPox is expected to begin soon in the Democratic Republic of Congo, with site preparation and staff training scheduled for early April 2026.
April 1, 2026 — This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising.
April 1, 2026 — This article has been disseminated on behalf of SPARC AI Inc. and may include paid advertising.